T2D progression can be controlled by lifestyle changes [11] and pharmacological therapies, including hypoglycemic or antihyperglycemic, insulin-sensitizing, or insulin secretion-enhancing drugs [12–14]. Here, INS is linked to type 2 diabetes mellitus.